2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 2)

In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on continuous glucose monitoring across key patient populations. Topics include CGM use in insulin treated diabetes, non insulin treated type 2 diabetes, chronic kidney disease, individualized management in CKD, compression lows, the lag between blood and interstitial glucose, and substances that may interfere with CGM accuracy.